Variables | Cases | PI3K (n, %) | H-Ras (n, %) | ||||
---|---|---|---|---|---|---|---|
Negative | Positive | P | Negative | Positive | P | ||
Gender | |||||||
 Male | 94 | 79 (84.0) | 15 (16.0) | 0.120 | 78 (83.0) | 16 (17.0) | 0.242 |
 Female | 74 | 55 (74.3) | 19 (25.7) |  | 56 (75.7) | 18 (24.3) |  |
Age (years) | |||||||
 < 54 | 87 | 70 (80.5) | 17 (19.5) | 0.816 | 71 (81.6) | 16 (18.4) | 0.537 |
 ≥ 54 | 81 | 64 (79.0) | 17 (21.0) |  | 63 (77.8) | 18 (22.2) |  |
T classification | |||||||
 T3 | 24 | 21 (87.5) | 3 (12.5) | 0.308 | 18 (75.0) | 6 (25.0) | 0.531 |
 T4 | 144 | 113 (78.5) | 31 (21.5) |  | 116 (80.6) | 28 (19.4) |  |
N classification | |||||||
 N0 | 87 | 75 (86.2) | 12 (13.8) | 0.031 | 73 (83.9) | 14 (16.1) | 0.166 |
 N1–3 | 81 | 59 (72.8) | 22 (27.2) |  | 61 (75.3) | 20 (24.7) |  |
M classification | |||||||
 M0 | 122 | 98 (80.3) | 24 (19.7) | 0.766 | 97 (79.5) | 25 (20.5) | 0.894 |
 M1 | 46 | 36 (78.3) | 10 (21.7) |  | 37 (80.4) | 9 (19.6) |  |
Clinical stage | |||||||
 III | 49 | 41 (83.7) | 8 (16.3) | 0.418 | 38 (77.6) | 11 (22.4) | 0.647 |
 IV | 119 | 93 (78.2) | 26 (21.8) |  | 96 (80.7) | 23 (19.3) |  |